Improving glucose monitoring for Hispanic adults with type 1 diabetes
FQHC Intervention for CGM Uptake in Hispanic Adults with T1D
This study is looking to help low-income Hispanic adults with type 1 diabetes use continuous glucose monitors more often, so they can better manage their health and avoid serious complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10898659 on NIH RePORTER |
What this research studies
This research aims to increase the use of continuous glucose monitoring (CGM) among low-income Hispanic adults with type 1 diabetes (T1D), who face significant health disparities. The study will implement a mixed-methods approach, including a pilot randomized controlled trial, to assess the feasibility of an intervention that addresses social determinants of health. By focusing on individual, family, and healthcare provider levels, the intervention seeks to enhance knowledge, motivation, and skills necessary for effective CGM use. The goal is to reduce the risk of severe complications associated with T1D in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are low-income Hispanic adults aged 21 and older who have been diagnosed with type 1 diabetes.
Not a fit: Patients who do not have type 1 diabetes or those who are not part of the Hispanic community may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced emergency visits for Hispanic adults with type 1 diabetes by increasing CGM usage.
How similar studies have performed: Previous research has shown that targeted interventions can successfully improve health outcomes in underserved populations, suggesting potential for success in this approach.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Newlin, Kelley — University of Connecticut Storrs
- Study coordinator: Newlin, Kelley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.